Health information designed to help you ask better questions.
Kevzira — Knowledge Today. A Healthier Tomorrow.
GLP-1 Guide

Understanding GLP-1 medicines without the hype.

Adults jogging together on a tree-lined path
Health is bigger than one medication. Movement, nutrition, sleep and ongoing care remain part of the conversation.

GLP-1 receptor agonists are medicines that act on pathways involved in blood glucose regulation, appetite and food intake. Different products have different FDA-approved indications, instructions, contraindications and risks.

Why people are talking about GLP-1s

Some GLP-1 medicines are approved for type 2 diabetes and some for chronic weight management in eligible patients. The approved use depends on the specific product.

Approved vs. compounded products

Important distinction: Compounded drugs are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality before marketing. A healthcare professional can explain when compounding may or may not be appropriate.

Questions worth asking

  • What is this specific medication approved to treat?
  • What benefits and risks are relevant to my history?
  • What side effects and warning signs should I understand?
  • Could it interact with medicines I already use?
  • How should progress be monitored?

Keep the whole picture in view

Medication decisions are one part of health. Nutrition, movement, sleep, existing conditions and other medications can all matter. Kevzira does not determine whether a GLP-1 medicine is appropriate for you.

Terminology you may encounter

GLP-1, GLP-1 receptor agonist, incretin, semaglutide and tirzepatide are not interchangeable terms. Some medicines act on more than one receptor pathway, and brand names, active ingredients and approved indications should be distinguished carefully.

Side effects and monitoring

Prescription information for individual medicines includes warnings, contraindications and adverse reactions. A qualified healthcare professional can explain which considerations apply to a specific person and what monitoring is appropriate.